Chan K Y-K, Liu W, Long J-R, Yip S-P, Chan S-Y, Shu X-O, Chua D T-T, Cheung A N-Y, Ching J C-Y, Cai H, Au G K-H, Chan M, Foo W, Ngan H Y-S, Gao Y-T, Ngan E S-W, Garcia-Barceló M-M, Zheng Wei, Khoo U-S
Department of Pathology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.
J Med Genet. 2009 Jan;46(1):32-9. doi: 10.1136/jmg.2007.057174. Epub 2008 Sep 9.
The BRCA1 gene is an important breast-cancer susceptibility gene. Promoter polymorphisms can alter the binding affinity of transcription factors, changing transcriptional activity and may affect susceptibility to disease.
Using direct sequencing of the BRCA1 promoter region, we identified four polymorphisms c.-2804T-->C (rs799908:T-->C), c.-2265C-->T (rs11655505:C-->T), c.-2004A-->G (rs799906:A-->G) and c.-1896(ACA)(1)-->(ACA)(2) (rs8176071:(ACA)(1)-->(ACA)(2)) present in Hong Kong Chinese. Each polymorphism was studied independently and in combination by functional assays. Although all four variants significantly altered promoter activity, the c.-2265T allele had stronger binding than the C allele, and the most common mutant haplotype, which contains the c.-2265T allele, increased promoter activity by 70%. Risk association first tested in Hong Kong Chinese women with breast cancer and age-matched controls and replicated in a large population-based study of Shanghai Chinese, together totalling >3000 participants, showed that carriers of the c.-2265T allele had a reduced risk for breast cancer (combined odd ratio (OR) = 0.80, 95% CI 0.69 to 0.93; p = 0.003) which was more evident among women aged >or=45 years at first diagnosis of breast cancer and without a family history of breast cancer (combined OR = 0.75, 95% CI 0.61 to 0.91; p = 0.004). The most common haplotype containing the c.-2265T allele also showed significant risk association for women aged >or=45 years without a family history of breast cancer (OR = 0.64, 95% CI 0.46 to 0.89; p = 0.008).
This comprehensive study of BRCA1 promoter polymorphisms found four variants that altered promoter activity and with the most significant contribution from c.-2265C-->T, which could affect susceptibility to breast cancer in the Chinese population. Its significance in other populations remains to be investigated.
BRCA1基因是一种重要的乳腺癌易感基因。启动子多态性可改变转录因子的结合亲和力,改变转录活性,并可能影响疾病易感性。
通过对BRCA1启动子区域进行直接测序,我们在香港华人中鉴定出4种多态性:c.-2804T→C(rs799908:T→C)、c.-2265C→T(rs11655505:C→T)、c.-2004A→G(rs799906:A→G)和c.-1896(ACA)(1)→(ACA)(2)(rs8176071:(ACA)(1)→(ACA)(2))。通过功能试验对每种多态性进行了单独和联合研究。尽管所有4种变体均显著改变了启动子活性,但c.-2265T等位基因的结合能力比C等位基因更强,并且包含c.-2265T等位基因的最常见突变单倍型使启动子活性提高了70%。在香港华裔乳腺癌女性和年龄匹配的对照中首次进行的风险关联研究,并在一项针对上海华人的大型基于人群的研究中进行了重复验证,总计超过3000名参与者,结果显示携带c.-2265T等位基因的个体患乳腺癌的风险降低(合并比值比(OR)=0.80,95%可信区间0.69至0.93;p = 0.003),这在首次诊断为乳腺癌时年龄≥45岁且无乳腺癌家族史的女性中更为明显(合并OR = 0.75,95%可信区间0.61至0.91;p = 0.004)。包含c.-2265T等位基因的最常见单倍型在首次诊断为乳腺癌时年龄≥45岁且无乳腺癌家族史的女性中也显示出显著的风险关联(OR = 0.64,95%可信区间0.46至0.89;p = 0.008)。
这项对BRCA1启动子多态性的全面研究发现了4种改变启动子活性的变体,其中c.-2265C→T的贡献最为显著,这可能影响中国人群对乳腺癌的易感性。其在其他人群中的意义仍有待研究。